tm logo
MTYKA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 04 Dec 2023

Last Applicant/ Owned by

3545 Cray Court

San Diego

CA

92121

Serial Number

88409002 filed on 30th Apr 2019

Registration Number

N/A

Correspondent Address

Eric R. Moran

McDonnell Boehnen Hulbert & Berghoff LLP

31st Floor

300 South Wacker Drive

Chicago IL 60606

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MTYKA

research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related toRead More

Classification Information


Class [042]

Computer & Software Services & Scientific Services


research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Class [005]

Pharmaceutical Products


pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors

Mark Details


Serial Number

No 88409002

Mark Type

No Service Mark

Attorney Docket Number

No MBHB 19-953

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Dec 2023ABANDONMENT - NO USE STATEMENT FILED
04th Dec 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06th May 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th May 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
05th May 2023SOU EXTENSION 5 GRANTED
02th May 2023SOU TEAS EXTENSION RECEIVED
02th May 2023SOU EXTENSION 5 FILED
03rd Nov 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01st Nov 2022SOU TEAS EXTENSION RECEIVED
01st Nov 2022SOU EXTENSION 4 FILED